Navigation Links
Gen-Probe to Webcast Presentations at Lehman and Cowen Healthcare Conferences
Date:3/12/2008

SAN DIEGO, March 12 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will present at the Lehman Brothers 11th Annual Global Healthcare Conference in Miami Beach on March 18, 2008 at approximately 3:15 p.m. Eastern Time, and at the Cowen and Company 28th Annual Healthcare Conference in Boston on March 19, 2008 at approximately 8:00 a.m. Eastern Time. Both presentations are scheduled to be webcast live and may be accessed through a link on the investors section of Gen-Probe's website at http://www.gen-probe.com. The webcasts will be available for 30 days following the events.

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has approximately 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to http://www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by any forward-looking statement. For information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we have filed with the SEC, including the Form 10-K for the year ended December 31, 2007, and all subsequent periodic filings made with the SEC. We assume no obligation and expressly disclaim any duty to update any forward-looking statement to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.

Contact:

Paula Izidoro

Investor Relations

858-410-8904


'/>"/>
SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007
2. Carl Hull Named President and Chief Operating Officer of Gen-Probe
3. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
4. Gen-Probe to Webcast Three Upcoming Presentations
5. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
6. Gen-Probe to Webcast Presentation at Bank of Americas 37th Annual Investment Conference
7. Exelixis Announces March 17 Webcast of Presentation at the Cowen and Company Annual Health Care Conference
8. Volcano Corporation Presentation at Cowen Healthcare Conference to be Webcast
9. MIGENIX Third Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
10. Wyeth Sets Webcast And Conference Call For 2008 First Quarter Earnings
11. Oncothyreon announces March 10th webcast of fourth quarter and full year financial results conference call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... 2016  Genprex, Inc. a biopharmaceutical company focused ... today announced that it has retained ICR Healthcare, ... communications and advisory firm, to develop and implement ... combine investor relations, public relations and digital communications ... of Genprex and its lead candidate Oncoprex, which ...
(Date:12/7/2016)... and ANN ARBOR, Mich. , Dec. ... company developing breakthrough immune modulatory medicines, announced today the ... Company,s lead therapeutic candidate, LYC-30937- E nteric C ... debilitating skin disease that is estimated to affect as ... States , with approximately 1.5 - 3 million ...
(Date:12/7/2016)... ... December 07, 2016 , ... Cambrian Innovation , ... facilities, today announced that one of the nation’s fastest growing craft breweries, ... purchase agreement (WEPA). Under the WEPA, a first for the industrial wastewater treatment ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... http://www.autoreactors.com and online shopping cart. The new website has been designed to ... essential digital components allow customers to access detailed product information, read educational industry ...
Breaking Biology Technology:
(Date:11/17/2016)... announces that it has just released a new white paper authored by Zettar that ... speed data transfer storage solutions. Photo - http://photos.prnewswire.com/prnh/20161116/440463 ... ... ... Setting up a high performance computing or HPC system can be a ...
(Date:11/15/2016)... 15, 2016 Research and Markets has announced ... 2021" report to their offering. ... ... by 2021 from USD 6.21 Billion in 2016, growing at a ... of the bioinformatics market is driven by the growing demand for ...
(Date:6/27/2016)... 27, 2016 Research and Markets has announced ... report to their offering. ... to grow at a CAGR of 12.28% during the ... on an in-depth market analysis with inputs from industry experts. The ... coming years. The report also includes a discussion of the key ...
Breaking Biology News(10 mins):